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Objective: This study was undertaken to study negative and positive arterial remodeling processes within self-expanding
carotid stents, their interaction, and the resulting changes in hemodynamics over 2 years, with duplex ultrasound
scanning.
Subjects and methods: One hundred twelve consecutive patients with 121 successfully stented carotid arteries were
examined with color-coded duplex ultrasound scanning the day after the stent procedure and at 3, 6, 12, and 24 months
of follow-up. The stent diameters at the proximal, middle, and distal regions, and the maximal neointimal thickness
(B-mode) and hemodynamic parameters were recorded. Pre-interventional plaques were assigned to three types: soft,
fibrous, and largely calcified.
Results: The diameters of the self-expanding stents steadily increased over 2 years (positive arterial remodeling), from
(mean SD) 5.80 0.89 mm to 6.77 0.98 mm in the proximal stent area, from 3.51 0.76 mm to 4.92 0.89 mm
in the middle stent area, and from 3.7  0.5 mm to 4.68  0.61 mm in the distal stent area (P < .001). Stent expansion
was most marked in the middle stent area, depending on the type of pre-interventional plaque. The extent in stent
expansion was more in soft than in fibrous and calcified plaques (P < .001). Neointimal thickness increased up to 12
months, and stabilized thereafter. The mean ( SD) neointimal thickness at 3, 6, 12, and 24 months was 0.61  0.28
mm, 0.97  0.39 mm, 1.06  0.36 mm, and 1.12  0.38 mm, respectively. These complex interactions resulted in the
dominance of negative remodeling secondary to neointimal proliferation, with an increased flow ratio during the first
year, from 1.16  0.37 at day 1 to 1.23  0.46 at 3 months, 1.67  1.37 at 6 months, and 1.57  0.70 at 12 months
(P < .001), followed by a tendency to decrease as a result of stent expansion thereafter (flow ratio at 24 months, 1.49 
0.70). Two of 121 stents (1.6%) had recurrent stenosis that required a secondary procedure.
Conclusions: Neointimal proliferation or negative arterial remodeling prevails up to 12 months, and may give rise to rare
stent recurrent stenosis. Stent expansion reduces this effect in the first year, and dominates in the second year. This might
contribute to the good mid-term outcome of carotid stenting. Poor stent expansion in heavily calcified plaques calls for
primary surgical management. (J Vasc Surg 2004;39:728-34.)In terms of both safety and efficacy, carotid artery
stenting has emerged as a potential alternative to surgical
treatment in the last few years.1 In general, recurrent ste-
nosis continues to be the “Achilles heel” of catheter inter-
ventions. The incidence of carotid stent recurrent stenosis,
however, has been low in several single-center studies2-5
and in a global questionnaire survey,6 in which the rate of
recurrent stenosis reported was 3.46% in 12 months.
Color-coded duplex ultrasound scanning of the carotid
artery is an established method to assess the outcome of
surgery, and has been used in large surgical trials.7-9 Its
diagnostic accuracy with respect to degree of stenosis has
been published in a consensus document.10 Comparing
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parameters, Robbin et al11 were the first to show that
duplex ultrasound scanning may be an acceptable method
for evaluation of patency or recurrent stenosis in carotid
stents.
Recurrent stenosis in the course of wound healing after
endovascular treatment is considered the biologic overre-
sponse to vascular injury secondary to endovascular inter-
vention.12 Two major mechanisms may contribute to lu-
men loss. Neointimal hyperplasia may occur in an early
phase of vascular response, and changes in the local constit-
uents of the arterial wall may lead to arterial shrinking in the
chronic wound-healing phase. Stents provide a scaffold to
maintain the arterial lumen and to prevent the artery from
shrinking in the late phase of stent healing.12 Therefore
recurrent stenosis after stent deployment is mainly due to
neointimal hyperplasia.13
Recently the neointimal proliferation within carotid
Wallstents was studied in a prospective ultrasound-based
study comprising more than a hundred successfully stented
carotid arteries over 24 months.14 The typical neointimal
structure was clearly visualized at the 3-month follow-up
and after, increasing in thickness to the 12-month follow-
up, while no further relevant changes in the neointima were
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ports on dynamic changes in the ultrasonic anatomy of
carotid stents over time are lacking so far.
The purpose of the present prospective study, compris-
ing 121 carotid arteries in 112 consecutive patients, was to
answer the following questions by means of color-coded
duplex ultrasound scanning over a 24-month follow-up:
● What is the balance between neointimal proliferation
within the carotid stent (negative remodeling) and the
expansion of the diameter of the self-expanding carotid
stent (positive remodeling) over time?
● Does the type of plaque before the intervention have a
role in positive remodeling of carotid Wallstents?
● How is the resultant development of hemodynamic pa-
rameters within carotid stents, the result of negative or
positive remodeling over 2 years?
METHODS
Patients. Between January 1997 and November
1998, 121 carotid arteries in 112 consecutive patients (77
men) were successfully stented. The study complied with
the Declaration of Helsinki and was approved by the insti-
tutional ethics committee, and written informed consent
was obtained from all patients. Bilateral stents were placed
in 9 patients, in the same session in 6 patients.
The indication for carotid stenting15 was based on
angiographically documented stenosis greater than 70%. In
patients with symptoms (39 of 112), there also had to be
high clinical suspicion that the neurologic manifestations
were due to microembolization from the carotid plaque,
and the interval between onset of hemispheric symptoms
and the procedure had to be less than 6 months. In patients
without symptoms, fulfillment of any one of several criteria
supported stent treatment, including rapid lesion progres-
sion within 6 months, documented on duplex ultrasound
scans; silent cerebral infarction on a CT scan, consistent
with thromboembolism from the carotid plaque; very high-
grade stenosis (90%); contralateral occlusion or severe
stenosis; or surgeon request before major surgery.
Carotid artery stent placement was performed by one
interventionist, without a protective device, in this early
series, in accordance with a previously described technical
protocol.15 Self-expanding Wallstents (Boston Scientific,
Natick, Mass) with a rolling membrane were used through-
out, which had been sized to the common carotid segment
measured from the selective angiogram. Diameters of the
stents used were 7 mm (n  5), 8 mm (n  31), 9 mm (n
 36), and 10 mm (n 49). Deployment was followed by
dilation within the stent with a balloon catheter that was 5
to 6 mm in diameter. Inasmuch as most arteriosclerotic
lesions were located at the carotid bifurcation, the stents
were placed across the bifurcation from the common ca-
rotid artery into the internal carotid artery.
Study design. The prospective follow-up examination
included duplex ultrasound scanning and clinical examina-
tion. Follow-up visits were scheduled the day before, the
day after, and 3, 6, 12, and 24 months after stent place-ment. Negative remodeling due to neointimal proliferation
and positive remodeling secondary to expansion of the
stented carotid artery were correlated with the hemody-
namic parameters.
Concomitant anti-platelet therapy was started in this
early series 3 days before the intervention, and consisted of
ticlopidine 250 mg twice a day plus acetylsalicylic acid
(ASA) 100 mg/day. ASA was discontinued after 4 weeks.
Ticlopidine therapy was continued for 1 year, then con-
verted to ASA 100 mg/day. Similar or identical regimens
have been successfully applied in carotid stenting.15-17
Angiographic evaluation. Angiographic grading of
primary stenoses and residual stenoses after carotid artery
stenting was done analogous to the North American Symp-
tomatic Carotid Endarterectomy Trial.8 Selective angio-
grams were obtained in at least two planes. Measurements
were made on the angiographic view that showed the most
severe narrowing. The diameter for calculation was mea-
sured with manual caliper placement.
Color-coded duplex ultrasound scanning. All ex-
aminations were performed with a Vingmed System 5
(VINGMED SOUND AIS; General Electric, Horton,
Norway) with a 10-MHz linear array transducer (axial
resolution, 0.2 mm); the Doppler frequency of the duplex
transducer was 5 MHz. Two experienced sonographers
performed all ultrasound measurements. Strict duplex set-
tings14 were applied. Depth gain compensation, dynamic
range, frame rate, and persistence values were held con-
stant. Depth and magnification were adjusted to patient
anatomy. The gain was turned so that the intima media of
the native common carotid artery proximal to the stent was
clearly visualized. The angle of insonation used to obtain
B-mode images for morphologic assessment was near 90
degrees. The examination included the common carotid
artery proximal to the stent, the entire stent, and the ICA
distal to it. Morphologic measurements were taken in the
B-mode from three planes in the longitudinal view: ante-
rior, lateral, and posterior. The calipers for measurement
were placed manually. The Doppler curve was obtained
with an angle of insonation of 60 degrees or less while using
angle correction.
The following morphologic parameters were measured
at follow-up: (1) Stent diameters were measured at the
proximal and cephalad ends of the stent and in the middle
stent area, at the site of the plaque causing the pre-inter-
ventional stenosis identified directly in the B-mode (Fig 1)
or by its distance from the bifurcation. (2) The maximal
thickness of the neointima or the layer between the stent
and the perfused lumen was measured as reported recent-
ly.14 All data concerning the thickness of the neointima
refer to the proximal stent. The individual maximal thick-
ness of the neointima in the proximal stent area was the
basis for further calculation, for the following reasons. The
duplex settings were adjusted to optimal visualization of
the intima media thickness of the native common carotid
artery proximal to the stent. The best visualization of the
neointima was achieved in the proximal stent, whereas in
the middle and distal stent area its visualization was occa-
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tient anatomy.
Stent diameters were measured from inner surface to
inner surface, with care taken not to exert pressure on the
artery while scanning. These measurements were per-
formed in the B-mode (Fig 1).
Assessment of carotid plaque type before stenting was
based on the pre-interventional duplex ultrasound scan-
ning B-mode image, assisted by color Doppler scanning in
cases of echolucent plaques. Plaques were assigned to three
types in accordance with the Asymptomatic Carotid Steno-
sis and Risk of Stroke study18: soft plaque, mostly echolu-
cent; fibrous plaque, mostly echogenic and hard; and
largely calcified plaque, with extensive shadowing and very
hard.
The plaque was analyzed visually by two experienced
observers. Agreement between the two observers was high
(weighted   0.84) and statistically significant (P 
.0001). In case of disagreement, the plaques were assigned
by consensus.
The acceptable reproducibility of the measurements of
the maximal thickness of the layer between the stent and
the perfused lumen (in millimeters) has been reported.14
The reproducibility of the stent diameter measurements
was confirmed by two sonographers, who repeatedly mea-
sured stent diameters in 8 patients, in three different stent
positions, three times a day for 3 consecutive days. Analysis
of variance showed that the variance attributable to patients
Fig 1. B-mode image of a carotid stent at 12 months sho
were measured. Small arrows mark the ingrowing “neo
luminal side of the stent and a less echogenic area undern
carotid artery (CCA) proximal to the stent. Pre-interve
arrows.(with a variance component of 0.5) and to differences
between the three positions investigated (1.85), as well as
the interaction between these terms (0.36), is considerably
larger than the variance attributable to the two sonogra-
phers (0.0002), the day of the measurement (0), or the
measurement repetitions (0.0002).
To grade stent recurrent stenoses, the same hemody-
namic parameters as those proposed by Nicolaides et al19
for the native carotid artery were applied, that is, peak
systolic velocity and end-diastolic velocity within the nar-
rowest site of the stent. However, the basis for grading
stent recurrent stenoses was the flow ratio, calculated with
the formula In-stent internal carotid artery peak systolic
velocity/common carotid artery peak systolic velocity. A
flow ratio greater than 4 referred to greater than 70%
recurrent stenosis, and a flow ratio greater than 2.6 referred
to greater than 50% recurrent stenosis.
Statistical analysis. Results are given as mean  SD.
All tests were two-sided, and P  .05 was considered
significant. Analysis of variance models for repeated mea-
sures were used to evaluate the trend over time. Spatial
covariance structures were used for changes relative to day
1, because the measurements were unequally spaced in
time. The baseline measurements were also included as
covariates. Because of the different behavior of some vari-
ables in the early and mid-term phases after stenting, inter-
vention analysis was performed with a dummy variable. The
Pearson coefficient was used to determine correlations be-
e sites where proximal, middle, and distal stent diameter
a” within the stent, a uniformly echogenic line on the
similar to the intima-media layer of the native common
al plaque, compressed by the stent, is marked by largews th
intim
eath,
ntion
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and its interaction with the time trend was also considered.
Calculations were made with the SAS statistical analysis
system, version 8.02 (SAS, Chicago, Ill).
RESULTS
Demographic data for the 112 patients (77 men) in-
cluded mean (SD) age, 69  10 years, and mean body
mass index, 26 4. Risk factors included arterial hyperten-
sion in 93 patients (83%), diabetes mellitus in 43 patients
(38.4%), cigarette smoking in 64 patients (57%), and hy-
perlipidemia in 94 patients (84%). Thirty-nine of 112 pa-
tients had symptoms, and 6 of 112 patients had recurrent
stenoses after carotid surgery.
In 109 of 121 consecutively stented carotid arteries
(112 patients) the scheduled controls with color-coded
duplex ultrasound scanning could be completed up to 24
months. Twelve patients were lost to follow-up: 9 patients
died, of causes unrelated to the intervention; 3 patients
dropped out, 2 because of recurrent stenosis followed by a
second intervention, and 1 because of disabling stroke
ipsilateral to the stent after thoracic surgery, due to cessa-
tion of antiplatelet therapy 2 months after carotid stenting.
In another 8 patients morphologic measurements could
not be completed because of technical problems, such as
extensive shadowing or very distal bifurcation; thus exact
measurements of the distal or middle stent diameter could
not be obtained.
Peri-interventional angiographic results. The pre-
treatment degree of carotid stenosis on angiograms was
78%  11%, and the residual stenosis immediately after
stenting was 5%  10%.
Dynamics of stent diameter during follow-up. At
the three stent sites (proximal, middle, distal) a significant
increase (P  .0001) in mean stent diameter from day 1 to
3, 6, 12, and 24 months was observed (Table). The most
pronounced stent expansion occurred in all three sites
within the first 3 months, whereas the diameters continued
to expand slowly thereafter. The most interesting develop-
ment in stent diameter was observed in the middle stent
area adjacent to the original plaque. The diameter was
Dynamics of stent diameters, neointima, and hemodynami
Day 1
(N  121) (N
Proximal stent diameter (mm) 5.80  0.98 6.1
Middle stent diameter (mm) 3.51  0.76 4.0
Distal stent diameter (mm) 3.67  0.55 4.0
Neointima (mm) * 0.6
Carotid flow ratio 1.16  0.37 1.2
Peak systolic velocity, ICA (m/s) 0.75  0.27 0.8
End-diastolic velocity, ICA (m/s) 0.23  0.12 0.2
Peak systolic velocity, CCA (m/s) 0.71  0.61 0.7
Values represent mean  SD.
N, Number of carotid stents evaluated at follow-up; ICA, internal carotid a
*At day 1 the neointima is not visualized in duplex ultrasound scans.narrowest at day 1, signaling some residual stenosis due to
the neighboring plaque. However, later it revealed the
most pronounced increase in stent diameter of all three
sites. At 3 months it exceeded the diameter of the distal
stent (Fig 2, A; Table). Expressed in percentages, the
expansion of the middle stent diameter was 40  23%
(range, 0%-116%; baseline, 3.51  0.76 mm), compared
with 18%  13% (range, 0%-83%; baseline, 5.80  0.98
mm) for the proximal stent diameter and 30%  18%
(range, 0%-91%; baseline, 3.67  0.55 mm) for the distal
stent diameter. At all three sites the baseline stent diameter
was inversely correlated with the quantity of expansion up
to 24 months (P  .001).
Influence of plaque composition on dynamics of
diameter in the middle stent area. The middle stent area
adjacent to the original plaque was the most sensitive.
Therefore it appeared worthwhile to investigate the influ-
ence of the composition of the pre-interventional plaque as
assessed with sonography, based on the dynamics of the
middle stent diameter. Expansion of the middle stent di-
ameter was different in the three types of plaques (P 
.0001): It was most pronounced in “soft” plaques, medium
in “fibrous” plaques, and less pronounced in “calcified”
plaques (Fig 2, B). In contrast, expansion of the proximal
and distal stent diameter was independent of the type of
plaque (P  .05).
Other potential influences on the dynamics of stent
expansion. In the six recurrent stenoses after carotid sur-
gery the dynamics in middle stent diameter were signifi-
cantly different from the group with primary stenosis. Its
expansion was weaker (P .038) during the first 6 months,
even at 12 months, and more pronounced in the second
year (P  .030). However, no significant difference was
observed between symptomatic and asymptomatic stenosis
(P  .05).
The development of the ingrowing neointima during
follow-up was recently reported.16 Mean values of the
maximal neointimal thickness at the proximal stent area at
follow-up visits are included in the Table. There is a signif-
icant increase in the maximal thickness of neointima over
time (P .0001); a substantial increase was noted up to the
Follow-up
8)
6 Mo
(N  118)
12 Mo
(N  111)
24 Mo
(N  109)
.98 6.37  0.96 6.57  0.94 6.77  0.98
.95 4.28  0.90 4.60  0.85 4.92  0.89
.60 4.24  0.61 4.40  0.62 4.68  0.61
.28 0.97  0.39 1.06  0.36 1.12  0.38
.46 1.67  1.37, 1.57  0.70 1.49  0.70
.34 0.99  0.48 1.01  0.37 1.00  0.39
.12 0.31  0.20 0.32  0.12 0.31  0.11
.42 0.66  0.25 0.68  0.24 0.72  0.21
CCA, common carotid artery.cs
3 Mo
 11
6  0
7  0
4  0
1  0
3  0
8  0
8  0
0  0
rtery;
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up to the 12-month follow-up visit, and was evidently
stable during the second year (Fig 3).
Dynamics of the carotid flow ratio during follow-
up. The mean flow ratio increased significantly (P .001)
up to the 6-month follow-up (from 1.16 0.37 to 1.67
1.37, or 56% from baseline), remained rather stable there-
after up to 12 months, and decreased slightly (P  .05) in
the second year (Fig 3; Table). Two patients dropped out
because of greater than 70% recurrent stenosis, which was
followed by a second intervention. One of these patients
(flow ratio, 13.6) was excluded after the 6-month fol-
low-up visit, and the other (flow ratio, 10.2) after the
12-month follow-up visit; these patients were not included
in the analysis.
The dynamics of the peak systolic velocity and the
end-diastolic velocity during follow-up developed similarly
(Table). Both of these flow parameters increased signifi-
cantly up to 6 months of follow-up (P  .001), and
stabilized thereafter.
Influence of neointimal proliferation within the
stent and stent diameter on the dynamics of the flow
ratio. A significant positive correlation between the
change in flow ratio versus change in maximal thickness of
the neointima was found (  .14; P  .003). No signifi-
cant correlation was found between stent diameter (irre-
Fig 2. A, Development of mean (SD) proximal, middle, and
distal stent diameters over 24 months. B, Influence of type of
pre-interventional plaque (soft, fibrous, calcified) on development
of mean middle stent diameter, the site of the pre-interventional
plaque, over time (see text).spective of neointimal ingrowth) and flow ratio, however (P
 .05).
DISCUSSION
To our knowledge, the present study is the first to
examine two counteracting mechanisms in carotid artery
stenting, namely, positive arterial remodeling or stent ex-
pansion and negative arterial remodeling or lumen narrow-
ing by neointimal proliferation, while offering an explana-
tion for the resulting changes in stent hemodynamics,
mirrored by the flow ratio, over time.
Carotid Wallstents expanded steadily from day 1 after
deployment over the entire follow-up of 2 years (P  .001).
As a whole, stent expansion was most pronounced during
the first 3 months after deployment, and most distinct in
the middle stent region, adjacent to the original plaque.
Furthermore, expansion of the middle stent region de-
pended on the type of plaque, which was classified visually
at ultrasound scanning performed before stenting. The
expansion was most pronounced in “soft” plaques, fol-
lowed by “fibrous” plaques and, finally, “calcified” plaques
(P  .0001).
In the present study the stent size was usually chosen
according to the common carotid artery segment, which
resulted in a markedly oversized self-expanding stent in the
ICA segment. The effect of stent oversizing was studied by
Piamsomboon et al,20 who analyzed six different stent-
artery ratios in oversized carotid stenting (1.4-2). These
authors found that the late lumen loss indexes were signif-
icantly lower in the groups with a high stent-artery ratio
than in those with a low stent-artery ratio (P  .01). Stent
oversizing might have favored the continuous increase in
stent diameter over the entire 2-year follow-up by exerting
steady radial pressure against the arterial wall in this study.
The difference in the dynamics of middle stent expan-
sion between recurrent stenoses after carotid surgery and
primary carotid stenoses might be an interesting additional
aspect, that is, weaker dilation up to 6 months (P  .038),
but more pronounced dilation in the second year (P 
.030) in the surgical recurrent stenosis group. However,
the small number of surgical recurrent stenoses in this
cohort limits the interpretation of this finding.
Fig 3. Development of carotid ratio and ingrowing neointima in
carotid stents over 24 months (mean  SD).
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proliferation (from zero at day 1 to a mean of 1.0 mm at 6
months and 1.1 mm at 12 months; P  .0001)14 counter-
acted the positive vascular remodeling process (Fig 2, A;
Fig 3). Thus the flow ratio increased on average from 1.1 to
1.7 at 6 months and 1.7 at 12 months of follow-up (P 
.0001). During the second year no further change in neo-
intimal thickness was observed (P  .05). After a further
steady increase in stent diameter during this period, the
flow ratio was slightly reduced at the 24-month follow-up;
however, the reduction was not statistically significant (P
.05).
With regard to the time course of negative and positive
arterial remodeling and their complex interaction, neointi-
mal proliferation predominates during the first year,
whereas stent expansion might overweigh in the second
year. It should be mentioned that recurrent stenoses in
self-expanding carotid stents are reported nearly exclusively
during the first year,21 a phase with some predominance of
neointimal proliferation; in these rare cases the imbalance
of negative and positive remodeling might be due to a
specific prevalence of neointimal proliferation, or to re-
duced stent expansion in cases of calcified plaques, or both.
The balance of positive and negative remodeling has been
meticulously investigated in coronary stents with intravas-
cular ultrasound, mainly on the basis of mid-term results.22
In coronary stents, neointimal proliferation is a major factor
in stent dilatation, leading to the well-known relatively high
percentage of coronary stent recurrent stenoses.22 The
reasons for this difference, that is, the moderate develop-
ment of neointima and the low rate of recurrent stenosis in
carotid stenting, might be complex; the wide lumen and
the elastic type of the carotid artery versus the rather narrow
coronary artery of the non-elastic type might have a role.
Similar differences in the rate of stent recurrent stenosis
exist in peripheral arteries, that is, a low rate in the wide iliac
artery of elastic type versus a higher rate in the femoropop-
liteal arteries.23,24 In addition to biologic differences be-
tween coronary arteries and the carotid artery with respect
to neointimal proliferation within stents, differences in the
methodologic approach also must be considered, such as
high-frequency (30 MHz) intravascular ultrasound in
coronary arteries25 and 10-MHz linear transducers with
the transcutaneous approach in carotid arteries. The advan-
tage of the transcutaneous approach is obvious: noninvasive
repetitive measurements over several years, with no ethical
difficulties.
A limitation of this study is that is was a prospective
non-controlled single-center study, which exclusively ad-
dressed self-expanding Wallstents, applying the platelet-
active therapy as described. However, the results provide
basic data on the development of morphologic and hemo-
dynamic duplex parameters over 2 years.
In conclusion, in the early phase of the stent healing
process, negative arterial remodeling due to neointimal
proliferation14 and increase in flow parameters is predomi-
nant. This phase calls for enforced platelet-active therapy
and careful observation of patients. Positive arterial remod-eling or a steady increase in stent diameter due to the
mechanical forces of the self-expanding oversized Walls-
tents dominate in the second year, and might additionally
contribute to the good mid-term outcome after carotid
stenting. However, the subject requires further long-term
observation. Poor stent expansion in heavily calcified
plaques could serve as a rationale for primary surgical
management in these patients. Our data on remodeling in
carotid stents provide a better understanding of hemody-
namics. The maximal neointimal thickness in the proximal
stent might be a good predictor of stent recurrent stenoses,
but in routine clinical practice hemodynamic criteria will
not be replaced.
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